Tiffany N. Smith, Ph.D.
Affiliations: | 2011 | Psychology | University of South Florida, Tampa, FL, United States |
Area:
Psychometrics Psychology, OrganizationalGoogle:
"Tiffany Smith"Mean distance: 6095.02
Parents
Sign in to add mentorWalter Borman | grad student | 2011 | University of South Florida | |
(Using Stratified Item Selection to Reduce the Number of Items Rated in Standard Setting.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Trucco M, Barredo J, Goldberg J, et al. (2017) Abstract CT145: A phase I window, dose escalating and safety trial of Metformin in combination with induction chemotherapy (VPLD)in relapsed/refractory acute lymphoblastic leukemia: NCT01324180 Cancer Research. 77 |
Kumar NB, Pow-Sang J, Egan KM, et al. (2015) Randomized, Placebo-Controlled Trial of Green Tea Catechins for Prostate Cancer Prevention. Cancer Prevention Research (Philadelphia, Pa.) |
Kumar NB, Pow-Sang J, Egan K, et al. (2015) Effect of green tea catechins in prostate cancer chemoprevention. Journal of Clinical Oncology. 33: 1572-1572 |
Kumar NB, Pow-Sang J, Egan KM, et al. (2015) Abstract PR06: Effect of polyphenon E on progression to prostate cancer after diagnosis of high grade prostatic intraepithelial neoplasia Cancer Prevention Research. 8 |
Taing MU, Smith T, Singla N, et al. (2013) The relationship between learning goal orientation, goal setting, and performance: A longitudinal study Journal of Applied Social Psychology. 43: 1668-1675 |
Kumar N, Crocker T, Smith T, et al. (2012) Prostate Cancer Chemoprevention Targeting Men with High-Grade Prostatic Intraepithelial Neoplasia (HGPIN) and Atypical Small Acinar Proliferation (ASAP): Model for Trial Design and Outcome Measures. Journal of Clinical Trials. 2 |
Kumar N, Crocker T, Smith T, et al. (2012) Prostate Cancer Chemoprevention Targeting High Risk Populations: Model for Trial Design and Outcome Measures. Journal of Cancer Science & Therapy. 2011 |
Kumar N, Crocker T, Smith T, et al. (2012) Challenges and potential solutions to meeting accrual goals in a Phase II chemoprevention trial for prostate cancer. Contemporary Clinical Trials. 33: 279-85 |